The revenue stands at ₹702.70 crore, reflecting a quarter-on-quarter *(QoQ) increase of 6.50 per cent from ₹659.80 crore. This corresponds to a year-on-year *(YoY) growth of 16.61 per cent.
Operating Profit stands at ₹186.80 crore, reflecting a quarter-on-quarter *(QoQ) increase of 25.20 per cent from ₹149.20 crore. This corresponds to a year-on-year *(YoY) growth of 10.53 per cent.
PBDT stands at ₹204.70 crore, reflecting a quarter-on-quarter *(QoQ) increase of 23.02 per cent from ₹166.40 crore. This corresponds to a year-on-year *(YoY) growth of 7.85 per cent.
Profit Before Tax stands at ₹160.10 crore, reflecting a quarter-on-quarter *(QoQ) increase of 28.80 per cent from ₹124.30 crore. This corresponds to a year-on-year *(YoY) growth of 4.37 per cent.
Net Profit stands at ₹132.20 crore, reflecting a quarter-on-quarter *(QoQ) increase of 44.64 per cent from ₹91.40 crore. This represents a 14.98 per cent year-on-year *(YoY) decline for the same year.
in ₹ cr
in ₹ cr
in ₹ cr
in ₹ cr
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Dr Lal Pathlabs | -0.93% | 0.51% | 9.57% | 10.71% | -0.12% | 12.20% |
| Narayana Hrudaya | -0.21% | -1.40% | 2.16% | -0.03% | 4.71% | 3.25% |
| Global Health | 0.59% | -1.19% | 10.30% | 4.80% | 2.08% | -3.37% |
| Krishna Institu. | 3.74% | 10.07% | 16.92% | 13.70% | 17.10% | 21.61% |
| Syngene Intl. | -2.52% | -0.94% | 12.52% | 6.90% | -28.92% | -27.43% |
| Poly Medicure | -5.73% | -4.91% | 8.46% | 22.72% | -17.80% | -32.07% |
| Dr Agarwal's Hea | -1.43% | -0.86% | 0.22% | -1.41% | -14.54% | 15.97% |
Chairman cum Managing Director : Arvind Lal
Whole-time Director : Vandana Lal
Whole Time Director & CEO : Om Prakash Manchanda
Director : Rahul Sharma
Independent Director : Arun Duggal
Independent Director : Anoop Mahendra Singh
Independent Director : Sunil Varma
Independent Director : Harneet Singh Chandhoke
Independent Director : Saurabh Srivastava
Company Secretary : Rajat Kalra